| Systemic Therapy and Sequencing Options in Advanced Hepatocellular Carcinoma: A Systematic Review and Network Meta-analysis MB Sonbol, IB Riaz, SAA Naqvi, DR Almquist, S Mina, J Almasri, S Shah, ... JAMA oncology, e204930-e204930, 2020 | 166 | 2020 |
| A Living, Interactive Systematic Review and Network Meta-analysis of First-line Treatment of Metastatic Renal Cell Carcinoma IB Riaz, H He, AJ Ryu, R Siddiqi, SAA Naqvi, Y Yao, M Husnain, ... European urology, 2021 | 48 | 2021 |
| First-line Systemic Treatment Options for Metastatic Castration-Sensitive Prostate Cancer: A Living Systematic Review and Network Meta-analysis IB Riaz, SAA Naqvi, H He, N Asghar, R Siddiqi, H Liu, P Singh, DS Childs, ... JAMA oncology, 2023 | 35 | 2023 |
| Disparities in the Inclusion of Racial and Ethnic Minority Groups and Older Adults in Prostate Cancer Clinical Trials: A Meta-analysis IB Riaz, M Islam, W Ikram, SAA Naqvi, H Maqsood, Y Saleem, A Riaz, ... JAMA oncology, 2022 | 30 | 2022 |
| Direct Oral Anticoagulants Compared With Dalteparin for Treatment of Cancer-Associated Thrombosis: A Living, Interactive Systematic Review and Network Meta-analysis IB Riaz, HE Fuentes, SAA Naqvi, H He, AJ Tafur, L Padranos, ... Mayo Clinic Proceedings, 2021 | 22 | 2021 |
| Janus Kinase Inhibitors and Risk of Venous Thromboembolism: A Systematic Review and Meta-analysis J Bilal, IB Riaz, SAA Naqvi, S Bhattacharjee, MR Obert, M Sadiq, ... Mayo Clinic Proceedings, 2021 | 20 | 2021 |
| Caffeine consumption and academic performance among medical students of Dow university of health science (DUHS), Karachi, Pakistan MS Khan, N Nisar, SAA Naqvi ANNALS OF ABBASI SHAHEED HOSPITAL AND KARACHI MEDICAL & DENTAL COLLEGE 22 (3 …, 2017 | 16 | 2017 |
| Accuracy of pre-operative parameters in predicting severe cholecystitis-A systematic review SM Khan, SH Emile, SH Barsom, SAA Naqvi The Surgeon, 2020 | 13 | 2020 |
| Disparities in Representation of Women, Older Adults and Racial/Ethnic Minorities in Immune Checkpoint Inhibitor Trials IB Riaz, M Islam, AM Khan, SAA Naqvi, R Siddiqi, KZR Khakwani, ... The American Journal of Medicine, 2022 | 12 | 2022 |
| Triplet therapy in metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis. SAA Naqvi, ZB Riaz, A Riaz, M Islam, R Siddiqi, W Ikram, MA Jafar, ... Journal of Clinical Oncology 40 (6_suppl), 136-136, 2022 | 10 | 2022 |
| Comparative Effectiveness of Anticoagulants in Patients With Cancer-Associated Thrombosis IB Riaz, H Fuentes, Y Deng, SAA Naqvi, X Yao, LR Sangaralingham, ... JAMA Network Open 6 (7), e2325283-e2325283, 2023 | 9 | 2023 |
| Medical students perspective about adverse effects of caffeine consumption MS Khan, SA Naqvi, N Nisar, F Nawab Rawal Medical Journal 43 (1), 156-160, 2018 | 7 | 2018 |
| Adjuvant Tyrosine Kinase Inhibitors in Renal Cell Carcinoma: A Concluded Living Systematic Review and Meta-Analysis IB Riaz, R Siddiqi, M Islam, H He, A Riaz, N Asghar, SAA Naqvi, ... JCO Clinical Cancer Informatics 5, 588-599, 2021 | 6 | 2021 |
| Outcomes of Revascularization and Factors Associated With Major Amputation in Patients With Lower Limb Arterial Injury: A Single-Center Retrospective Analysis G Ali, MF Berlas, NU Din, KU Rehman, WM Saleh, SAA Naqvi Cureus 13 (8), 2021 | 5 | 2021 |
| Assessment of Clinicians’ Satisfaction With Laboratories at a Public Sector Hospital in Karachi, Pakistan SAA Naqvi, A Hameed, Y Tanveer, ZAA Memon, R Masood Cureus 11 (7), 2019 | 5 | 2019 |
| Thyroid and Heart: Severe Three Vessel Coronary Artery Disease in a Middle-Aged Female with Hypothyroidism R Muneer, SAA Naqvi, O Gul, SDH Zaidi, MI Dar Cureus 11 (11), 2019 | 4 | 2019 |
| Incidence of second primary malignancies in patients with multiple myeloma receiving anti-CD38 monoclonal antibodies: a systematic review and meta-analysis A Mian, SAA Naqvi, A Ayaz, M Husnain, MA Aljama, GR Mohyuddin, ... Leukemia Research, 107324, 2023 | 3 | 2023 |
| Indirect comparisons of triplet therapy as compared to novel hormonal therapy doublets in patients with metastatic castration sensitive prostate cancer. SAA Naqvi, ZB Riaz, A Riaz, M Islam, R Siddiqi, W Ikram, MD Bin Zafar, ... Journal of Clinical Oncology 40 (16_suppl), 5083-5083, 2022 | 3 | 2022 |
| Blood-based tumor mutational burden from circulating tumor DNA and immune checkpoint inhibitors in advanced prostate cancer. G Rauterkus, A Hadadi, R Barnett, C Weipert, L Drusbosky, X Gao, ... Journal of Clinical Oncology 40 (6_suppl), 165-165, 2022 | 3 | 2022 |
| Clinical efficacy of lurbinectedin in metastatic neuroendocrine carcinomas of the genitourinary tract: Multi-institutional real-world experience. MJ Moussa, SAA Naqvi, J Khandelwal, MT Campbell, A Aparicio, ... Journal of Clinical Oncology 42 (4_suppl), 601-601, 2024 | 2 | 2024 |
